These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3280812)

  • 1. Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors.
    Shulman NB
    J Natl Med Assoc; 1988 Mar; 80(3):265-72. PubMed ID: 3280812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
    Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
    JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension in the Negro patient].
    Timmers GJ; Schouten JA; ter Wee PM; Gans RO
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):229-34. PubMed ID: 10086150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks.
    Bangalore S; Ogedegbe G; Gyamfi J; Guo Y; Roy J; Goldfeld K; Torgersen C; Capponi L; Phillips C; Shah NR
    Am J Med; 2015 Nov; 128(11):1195-203. PubMed ID: 26071821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment considerations for the hypertensive black patient.
    Saunders E
    J Fam Pract; 1988 Jun; 26(6):659-64. PubMed ID: 3288707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring treatment to minority patients.
    Saunders E
    Am J Med; 1990 Mar; 88(3B):21S-23S. PubMed ID: 2180289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.
    Brewster LM; Seedat YK
    BMC Med; 2013 May; 11():141. PubMed ID: 23721258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to treat hypertension in blacks: review of the evidence.
    Kola LD; Sumaili EK; Krzesinski JM
    Acta Clin Belg; 2009; 64(6):466-76. PubMed ID: 20101869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites.
    Ogedegbe G; Shah NR; Phillips C; Goldfeld K; Roy J; Guo Y; Gyamfi J; Torgersen C; Capponi L; Bangalore S
    J Am Coll Cardiol; 2015 Sep; 66(11):1224-1233. PubMed ID: 26361152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between birth weight and antihypertensive medication in black and white medicaid recipients.
    Lackland DT; Egan BM; Syddall HE; Barker DJ
    Hypertension; 2002 Jan; 39(1):179-83. PubMed ID: 11799099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: antihypertensive drug therapy in black patients.
    Brewster LM; van Montfrans GA; Kleijnen J
    Ann Intern Med; 2004 Oct; 141(8):614-27. PubMed ID: 15492341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension-related morbidity and mortality in African Americans--why we need to do better.
    Ferdinand KC; Saunders E
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1 Suppl 1):21-30. PubMed ID: 16415637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of hypertensive disease in black patients.
    Gibbs CR; Beevers DG; Lip GY
    QJM; 1999 Apr; 92(4):187-92. PubMed ID: 10396605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.
    Brewster LM; van Montfrans GA; Oehlers GP; Seedat YK
    Intern Emerg Med; 2016 Apr; 11(3):355-74. PubMed ID: 27026378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
    Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
    Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.
    Flack JM; Hamaty M
    J Hypertens Suppl; 1999 Feb; 17(1):S19-24. PubMed ID: 10340840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists in elderly and black hypertensive patients. Therapeutic controversies.
    Zing W; Ferguson RK; Vlasses PH
    Arch Intern Med; 1991 Nov; 151(11):2154-62. PubMed ID: 1683219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.